Integrative genomic analyses and fine-mapping of the 5q31.1 cytokine locus links food allergy risk to asthma and atopic dermatitis through shared causal variants
Autor/innen
- Ruiwen Zhou
- Matthew Patrick
- Qinmengge Li
- Erik Abner
- Yuntian Wu
- Rachael Bogle
- Lars Fritsche
- Philip E. Stuart
- Allison C. Billi
- George Freigeh
- Lea Franco
- Bridgette Kaul
- Ingo Marenholz
- Young-Ae Lee
- Hassan Vahidnezhad
- Amir Hossein Saeidian
- Hakon Hakonarson
- Xue Zhong
- Bingshan Li
- Kelly O'Shea
- James R. Baker
- Johann E. Gudjonsson
- Charles F. Schuler
- Lam C. Tsoi
Journal
- Journal of Allergy and Clinical Immunology
Quellenangabe
- J Allergy Clin Immunol
Zusammenfassung
BACKGROUND: Food allergy (FA) is a common immune-mediated disorder, yet its genetic architecture and underlying mechanisms remain incompletely understood.
OBJECTIVES: We aimed to characterize the genetic architecture of FA, refine association signals through multi-ancestry fine-mapping, and investigate shared genetic and regulatory mechanisms linking FA with asthma and atopic dermatitis (AD).
METHODS: We performed a multi-ancestry GWAS meta-analysis of FA including more than 16,000 cases and over 1 million controls of European, African, and East Asian ancestry. We used sequential conditional analysis and Bayesian fine-mapping to identify independent association signals and prioritize candidate causal variants. We further evaluated shared genetic architecture with asthma and AD through conditional colocalization analysis and integrated FA-associated variants with cis-eQTL and single-nucleus ATAC/RNA-seq data from blood and skin to nominate candidate target genes and disease-relevant cell types.
RESULTS: This trans-ancestry design enabled fine-mapping of the 5q31.1 locus (IL4, IL5, and IL13), revealing multiple independent disease-associated signals, including a secondary genome-wide significant variant (rs6873732; p ≤ 5 × 10) and a tertiary signal surpassing Bonferroni significance (rs4608913; p = 9.1 × 10). Bayesian fine-mapping identified credible causal variants that also associate with asthma and atopic dermatitis (AD). Genetic colocalization demonstrated that the primary FA signal at 5q31.1 aligns with a secondary AD signal (rs11242122), while the secondary and tertiary FA signals at 5q31.1 colocalize with two independent asthma signals (rs12652920 and rs77450473). Outside 5q31.1, we confirmed a genome-wide significant association at 1q21.3 and identified candidate loci at 11q13.5 and 18q21.33-q22.1, each showing strong evidence of shared causal variants (PP > 0.8) with asthma and AD. To connect genetic risk to cellular mechanisms, we integrated single-nucleus ATAC/RNA-seq from blood and skin. At 5q31.1, three variants within the primary credible set overlapped accessible chromatin in basophils and T cells, while seven tertiary-signal variants overlapped open chromatin in basophils, monocytes, keratinocytes, and CD8 T cells. Integration with cis-eQTL data demonstrated that primary and tertiary FA signals were associated with increased SLC22A5/IL13 expression and upregulation of IRF1, respectively.
CONCLUSION: Together, these findings refine the genetic architecture of FA, reveal shared and disease-specific mechanisms with related allergic diseases, highlight the value of integrating ancestry-diverse GWAS with multi-omics data to prioritize regulatory mechanisms in complex immune-mediated conditions.